Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Astrocytoma × fluoromisonidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Glioma 3 Glioblastoma 3 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Skin Neoplasms 1 Sarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Temozolomide 58 Radiotherapy 25 Bevacizumab 19 Magnetic Resonance Spectroscopy 16 Irinotecan 15 Carboplatin 13 Filgrastim 12 Carmustine 10 antineoplaston AS 2-1 8 antineoplaston A10 8 Surgical Procedures, Operative 8 sargramostim 7 Radiation 7 Etoposide 7 Vincristine 6 Specimen Handling 6 Radiotherapy, Intensity-Modulated 6 Procarbazine 6 Everolimus 6 Erlotinib Hydrochloride 6 Peripheral Blood Stem Cell Transplantation 5 O(6)-benzylguanine 5 Melphalan 5 Genetic Therapy 5 Cyclophosphamide 5 Aminolevulinic Acid 5 poly ICLC 4 etoposide phosphate 4 Topotecan 4 Thalidomide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡